Prostate-specific membrane antigen (PSMA) imaging such as positron emission tomography/computed tomography (PSMA PET/CT), currently the most sensitive molecular imaging modality for prostate cancer, enables high-resolution visualization of disease distribution throughout the body. Here, FOLH1 is linked to prostate cancer.